News | February 12, 2010

MITA Writes Prescription for Lowering Radiation Dose

February 12, 2010 - After the U.S. FDA announced it is launching a program designed to reduce unnecessary medical radiation exposure with a focus on computed tomography, nuclear medicine and fluoroscopy, the Medical Imaging & Technology Alliance (MITA) gave its prescription for lowering radiation.

MITA, an association representing the manufacturers, innovators and developers of medical imaging and radiation therapy systems, endorsed eight key principles to reduce exposure to unnecessary medical radiation, further minimize medical errors and improve reporting of adverse events.

“Over the past 20 years, innovations by imaging manufacturers have reduced radiation for many procedures by up to 75 percent,” said Dave Fisher, executive director of MITA. “MITA and its member companies look forward to working with all who are involved in patients’ continuum of care to reduce medical radiation, reduce the number of medical errors and enhance transparency and timeliness of error reporting while also continually improving technology to aid physicians in turning patients into survivors.”

To that end, MITA endorses:

• Expanding and integrating appropriateness criteria into physician decision-making.

• Creating a national dosage registry to ensure longitudinal tracking of dose levels for patients across America.

• Adopting a standardized method of storing of diagnostic imaging and radiation therapy information within electronic health records.

• Expanding mandatory accreditation for advanced imaging facilities.

• Establishing minimum standards for training and education for hospital and imaging facility personnel who perform medical imaging exams and deliver radiation therapy treatments.

• Develop enhanced operational safety procedures and checklists to reduce medical errors.

• Expanding and standardizing the reporting of medical errors associated with medical radiation across stakeholders in a manner that is transparent for patients, families and physicians.

• Working with stakeholders to develop radiation dose reference values to provide a data point to compare the dose level of a specific procedure. MITA commits to working with other stakeholders to develop the most appropriate way to incorporate this information into manufacturers’ technology.

Proclaimed by the New England Journal of Medicine as one of the top “developments that changed the face of clinical medicine” during the last millennium, medical imaging and radiation therapy have revolutionized health care delivery in America. In a recent Dartmouth-Stanford Survey of Medical Innovations, leading general internists concurred ranking MRI and CT technology as the most valuable medical innovation in the last 30 years. Likewise, radiation therapy has become the standard of care for treating most types of cancer. Radiation therapy offers highly personalized, noninvasive and cost-effective care for up to 60 percent of all diagnosed cancer patients in the United States.

MITA and its members have a long history of supporting the reduction in radiation dose. MITA’s members incorporate the radiation dose management and optimization principle, as low as reasonably achievable (ALARA), into all imaging procedures and technologies. In addition, MITA has collaborated with all medical community stakeholders in the in the Image Gently campaign to develop protocols specifically for children to optimize scan protocols, as well as on scanner calibrations using pediatric specific phantoms for improved image quality.

MITA also convened a stakeholders meeting in November including physicians, physicists, industry and Food and Drug Administration officials to discuss ways to prevent future medical errors that involve radiation. MITA is also co-sponsoring an upcoming radiation dose summit to further the education of providers and physicists on the new technologies our companies manufacture.

For more information: www.medicalimaging.org

Related Content

Fat Distribution in Women and Men Provides Clues to Heart Attack Risk
News | Women's Health | January 11, 2018
January 11, 2018 – It’s not the amount of fat in your body but where it is stored that may increase your risk for hea
Emergency Radiologists See Inner Toll of Opioid Use Disorders

Rates of Imaging Positivity for IV-SUDs Complications. Image courtesy of Efren J. Flores, M.D.

News | Clinical Study | January 11, 2018
January 11, 2018 – Emergency radiologists are seeing a high prevalence of patients with complications related to opio
Minimally Invasive Treatment Provides Relief from Back Pain

Lumbar spine MRI showing disc herniation and nerve root at baseline and one month after treatment

News | Interventional Radiology | January 11, 2018
The majority of patients were pain free after receiving a new image-guided pulsed radiofrequency treatment for low back...
CT Shows Enlarged Aortas in Former Pro Football Players

3-D rendering from a cardiac CT dataset demonstrating mild dilation of the ascending aorta.

News | Computed Tomography (CT) | January 11, 2018
Former National Football League (NFL) players are more likely to have enlarged aortas, a condition that may put them at...

Size comparison between 3-D printed prosthesis implant and a penny.

News | 3-D Printing | January 11, 2018
January 11, 2018 — Researchers using...
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
BlueCross BlueShield Companies in Eight States Issue Positive Medical Policies for HeartFlow FFRct Analysis
News | CT Angiography (CTA) | December 28, 2017
HeartFlow Inc. announced that Health Care Service Corp. (HCSC), which operates Blue Cross and Blue Shield plans in five...
Artificial intelligence was the number one topic in radiology in 2017.

Artificial intelligence was the number one topic of interest in radiology in 2017, based on the most popular articles and videos on ITN in 2017.

Feature | Imaging | December 28, 2017
The Imaging Technology News (ITN) website had another record year with more than 1.25 million page views in 2017.
Median Technologies Collaborating With Chinese Hospital for Lung Cancer Screening Programs
News | Lung Cancer | December 22, 2017
Median Technologies recently announced a research collaboration agreement with Xingtai People's Hospital, Xingtai City...
The Philips IQon Elite debuted at RSNA 2017 with features designed for emergency and trauma imaging. #RSNA2017, #RSNA17

The Philips IQon Elite debuted at RSNA 2017 with features designed for emergency and trauma care, as well as oncology. Image courtesy of Philips Healthcare

 

Feature | RSNA 2017 | December 21, 2017 | Greg Freiherr
The tenets of value-based medicine rippled across the exhibit floor like waves from a stone tossed in a pond.
Overlay Init